We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$7.94B
AUM Growth
-$936M
Cap. Flow
-$613M
Cap. Flow %
-7.72%
Top 10 Hldgs %
3.69%
Holding
3,355
New
457
Increased
1,134
Reduced
1,333
Closed
423

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$32.7M
2
LYB icon
LyondellBasell Industries
LYB
+$30.6M
3
PAYX icon
Paychex
PAYX
+$26.2M
4
LLY icon
Eli Lilly
LLY
+$25.3M
5
DOW icon
Dow Inc
DOW
+$24.9M

Top Sells

Rank Stock Value
1
LULU icon
lululemon athletica
LULU
+$35M
2
CPAY icon
Corpay
CPAY
+$30.7M
3
WMT icon
Walmart Inc
WMT
+$28.7M
4
ALGN icon
Align Technology
ALGN
+$27.8M
5
FISV
Fiserv Inc
FISV
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 19.86%
2 Healthcare 14.16%
3 Consumer Discretionary 13.51%
4 Industrials 13.25%
5 Financials 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRSH icon
2876
Freshworks
FRSH
$3.27B
$27K ﹤0.01%
+636
New +$28.5K
CSLT
2877
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$26K ﹤0.01%
16,745
-5,721
-25% -$11.2K
VINC
2878
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$25K ﹤0.01%
+77
New +$22.5K
RIGL icon
2879
Rigel Pharmaceuticals
RIGL
$750M
$24K ﹤0.01%
+661
New +$26K
TCRT icon
2880
Alaunos Therapeutics
TCRT
$4.86M
$24K ﹤0.01%
87
-145
-63% -$44.3K
XWEL icon
2881
XWELL
XWEL
$8.61M
$23K ﹤0.01%
+788
New +$25.3K
ASND icon
2882
Ascendis Pharma A/S
ASND
$16.8B
$22K ﹤0.01%
138
-508
-79% -$69.5K
CYRX icon
2883
CryoPort
CYRX
$762M
$22K ﹤0.01%
336
-11,720
-97% -$723K
SRAD icon
2884
Sportradar
SRAD
$3.85B
$21K ﹤0.01%
+945
New +$24.1K
JG
2885
Aurora Mobile
JG
$29.8M
$20K ﹤0.01%
591
-779
-57% -$34.8K
ONT
2886
Onterris Inc
ONT
$580M
$20K ﹤0.01%
+329
New +$17.2K
PTGX icon
2887
Protagonist Therapeutics
PTGX
$9.44B
$20K ﹤0.01%
1,117
-2,783
-71% -$119K
IMCR icon
2888
Immunocore
IMCR
$1.73B
$19K ﹤0.01%
+500
New +$16.9K
MNSO icon
2889
MINISO
MNSO
$3.75B
$19K ﹤0.01%
1,242
-22,652
-95% -$346K
MBII
2890
DELISTED
Marrone Bio Innovations, Inc.
MBII
$19K ﹤0.01%
20,550
-15,548
-43% -$18.7K
INO icon
2891
Inovio Pharmaceuticals
INO
$69M
$18K ﹤0.01%
+208
New +$20.9K
VTVT icon
2892
vTv Therapeutics
VTVT
$139M
$17K ﹤0.01%
277
-77
-22% -$5.8K
OTIC
2893
DELISTED
Otonomy, Inc.
OTIC
$17K ﹤0.01%
9,090
-14,526
-62% -$24.6K
JBIO
2894
Jade Biosciences
JBIO
$1.34B
$16K ﹤0.01%
+22
New +$12.3K
MTNB icon
2895
Matinas BioPharma
MTNB
$1.81M
$16K ﹤0.01%
+252
New +$10.9K
PUK icon
2896
Prudential
PUK
$35.2B
$16K ﹤0.01%
+400
New +$15.5K
NBSE
2897
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$16K ﹤0.01%
226
-116
-34% -$8.88K
ACHL
2898
DELISTED
Achilles Therapeutics
ACHL
$15K ﹤0.01%
+1,885
New +$12.4K
SREV
2899
DELISTED
ServiceSource International, Inc.
SREV
$15K ﹤0.01%
11,328
-4,091
-27% -$5.96K
DH icon
2900
Definitive Healthcare
DH
$75.3M
$13K ﹤0.01%
+310
New +$13.8K
114 115
116
117 118

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q3 2021 Portfolio in Review

As of Q3 2021, Cubist Systematic Strategies held 3,355 positions worth $7.94B, down 11% from $8.87B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

Cubist Systematic Strategies withdrew a net $613M in Q3 2021, closing 423 positions and reducing 1,333 holdings. Its most notable exit was Gentex, an estimated $8.02M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in Extra Space Storage worth $16.3M.

  • Cubist Systematic Strategies's largest Q3 2021 buy was Extra Space Storage: 97,283 shares worth $16.3M.
  • Cubist Systematic Strategies added most to Illumina in Q3 2021, an estimated $32.7M increase.
  • Cubist Systematic Strategies's biggest Q3 2021 reduction was lululemon athletica, cutting an estimated $35M.
  • Cubist Systematic Strategies fully exited Gentex in Q3 2021, selling an estimated $8.02M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.7% of its $7.94B portfolio in Q3 2021.
  • Cubist Systematic Strategies opened 457 new positions and closed 423 in Q3 2021.
  • Cubist Systematic Strategies's portfolio value fell 11% quarter-over-quarter to $7.94B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.